Eczematous sensitization, a novel pathway for allergic sensitization, can occur in an early stage of eczema - 02/10/14
Doi : 10.1016/j.jaci.2014.08.006
Kenji Matsumoto, MD, PhD ⁎ 
, Hirohisa Saito, MD, PhD
, Hirohisa Saito, MD, PhD Department of Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo, Japan
∗Corresponding author: Kenji Matsumoto, MD, PhD, Department of Allergy and Immunology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.
Key words : Eczema, erythema, sensitization, Langerhans cells, dendrite
Le texte complet de cet article est disponible en PDF.
| Supported in part by a grant from the National Research Institute for Child Health and Development (26-9 to K.M.) and by a Research of Allergic Diseases and Immunology in Heath Labour and Sciences Research Grant (H24-Men'eki-Ippan-002 to H.S.). |
|
| Disclosure of potential conflict of interest: K. Matsumoto has received research support (23-5) from and is employed by the National Research Institute for Child Health and Development; has received research support from the National Institute for Biomedical Innovation (#10-43); has received lecture fees from Merck Sharp and Dohme K.K., Ono Pharmaceutical, GlaxoSmithKline K.K., Kyorin Pharmaceutical, Ohtsuka Pharmaceutical K.K., Mitsubishi Tanabe Pharma, AstraZeneca K.K., Siemens Healthcare, Abbott Japan, and Sumitomo Dainippon Pharma; has received payment for manuscript preparation from Maruho; and has received payment for development of educational presentations from Gifu Pharmaceutical University. H. Saito is employed by the National Center for Child Health & Development; has received research support from the Ministry of Health, Labour & Welfare (H24-Men'eki-Ippan-006) and the Japan Society for the Promotion of Science (No. 23390262); has received lecture fees from Teijin Pharma, Shiseido, Merck Sharp and Dohme K.K., Taiho Pharmaceutical, Nippon Boehringer Ingelheim, Ono Pharmaceutical, GlaxoSmithKline K.K., Pfizer Japan, Novartis Pharma K.K, Kyowa Hakko Kirin, Kyorin Pharmaceutical, and Daiichi Sankyo; has received payment for manuscript preparation from Taiho Pharmaceutical; has received payment for development of educational presentations from Shimane University and Toho University; and has received travel support from Shimane University, the Japanese Society of Allergology, the Japanese Society of Pediatric Allergy & Clinical Immunology, and Pfizer Japan. |
© 2014
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 134 - N° 4
P. 865-866 - octobre 2014 Retour au numéro
Article précédent
- Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis
- Kazue Yoshida, Akiharu Kubo, Harumi Fujita, Mariko Yokouchi, Ken Ishii, Hiroshi Kawasaki, Toshifumi Nomura, Hiroshi Shimizu, Keisuke Kouyama, Tamotsu Ebihara, Keisuke Nagao, Masayuki Amagai
- Peanut allergy: Effect of environmental peanut exposure in children with filaggrin loss-of-function mutations
- Helen A. Brough, Angela Simpson, Kerry Makinson, Jenny Hankinson, Sara Brown, Abdel Douiri, Danielle C.M. Belgrave, Martin Penagos, Alick C. Stephens, W.H. Irwin McLean, Victor Turcanu, Nicolaos Nicolaou, Adnan Custovic, Gideon Lack
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?